The Hazards of Non-Ionizing Radiation of Telecommunication Mast in an Urban Area of Lagos, Nigeria

Autor: Akintonwa, A, Busari, AA, Awodele, O, Olayemi, SO

Publikováno v: African Journal of Biomedical Research; Vol 12, No 1 (2009); 31-35

The health hazards of non-ionizing radiation from telecommunication mast on the exposed community were assessed using a descriptive cross-sectional survey. The socio-demographic pattern and hazard profile of the respondent were documented. The result

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::3cfd7cf0c2023b582fc349b1137c8e03
https://www.ajol.info/index.php/ajbr/article/view/95129

Evaluation of antibiotic use and analysis of ciprofloxacin and gentamicin residue in fish samples from farms in Lagos, Nigeria.

Autor: Busari AA; Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria., Efejene IO; Deparment of Pharmacology, College of Medical and Health Sciences, Novena University, Ogume, Delta State, Nigeria., Olayemi SO; Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria., Orororo OC; Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Delta State University, P.M.B. 1, Abraka, Nigeria., Egbune EO; Department of Biochemistry, Faculty of Science, Delta State University, P.M.B. 1, Abraka, Nigeria. egbuneegoamaka@gmail.com.

Publikováno v: Environmental monitoring and assessment [Environ Monit Assess] 2024 Jan 09; Vol. 196 (2), pp. 127. Date of Electronic Publication: 2024 Jan 09.

Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.

Autor: Aina OO; Nigerian Institute of Medical Research, Lagos, Nigeria., Busari AA; College of Medicine of the University of Lagos Idi-Araba, Lagos, Nigeria., Oladele DA; Nigerian Institute of Medical Research, Lagos, Nigeria., Esezobor C; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Akase IE; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Okwuraiwe AP; Nigerian Institute of Medical Research, Lagos, Nigeria., Okoyenta CO; Nigerian Institute of Medical Research, Lagos, Nigeria., Otrofanowei E; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., James AB; Nigerian Institute of Medical Research, Lagos, Nigeria., Bamidele TA; Nigerian Institute of Medical Research, Lagos, Nigeria., Olopade OB; Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Ajibaye O; Nigerian Institute of Medical Research, Lagos, Nigeria., Musa AZ; Nigerian Institute of Medical Research, Lagos, Nigeria., Salako AO; Nigerian Institute of Medical Research, Lagos, Nigeria., Agabi OP; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Olakiigbe AK; Nigerian Institute of Medical Research, Lagos, Nigeria., Akintan PE; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Amoo OS; Nigerian Institute of Medical Research, Lagos, Nigeria., Ima-Edomwonyi E; Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Raheem TY; Nigerian Institute of Medical Research, Lagos, Nigeria., David AN; Nigerian Institute of Medical Research, Lagos, Nigeria., Akinbode GO; Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Nmadu N; Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Osuolale KA; Nigerian Institute of Medical Research, Lagos, Nigeria., Fadipe B; Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Abiola A; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Tade T; Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Audu RA; Nigerian Institute of Medical Research, Lagos, Nigeria., Adeyemo WL; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Ezechi OC; Nigerian Institute of Medical Research, Lagos, Nigeria., Bode C; College of Medicine of the University of Lagos /Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria., Salako BL; Nigerian Institute of Medical Research, Lagos, Nigeria.

Publikováno v: West African journal of medicine [West Afr J Med] 2023 Oct 31; Vol. 40 (10), pp. 1049-1059.

Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria.

Autor: Usman SO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria. osusman1967@gmail.com., Oreagba IA; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Kadri MR; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Adewumi OO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Akinyede A; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Agbaje EO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Abideen G; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Busari AA; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Hassan OO; Lagos University Teaching Hospital, Lagos, Nigeria., Akinleye MO; Department of Pharmaceutical Chemistry, Faculty of Pharmacy of the University of Lagos, Idi-Araba, Lagos State, Nigeria., Akanmu AS; Department of Haematology and Blood Transfusion, Faculty of Clinical Science, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.; Apin Clinic, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2021 Sep; Vol. 77 (9), pp. 1341-1348. Date of Electronic Publication: 2021 Mar 23.

High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.

Autor: Busari AA; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria., Oreagba IA; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria., Oshikoya KA; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria., Kayode MO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria., Olayemi SO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria.

Publikováno v: Nigerian medical journal : journal of the Nigeria Medical Association [Niger Med J] 2019 Nov-Dec; Vol. 60 (6), pp. 317-325. Date of Electronic Publication: 2020 Feb 24.